We read, with interest, the recent article by Shirke et al.[1] 'Tele-oncology in the COVID-19 Era: The Way Forward?', describing the benefits and limitations of tele-oncology and its role during the coronavirus disease 2019 (COVID-19) pandemic. As medical students experiencing the disruptions caused by COVID-19, this article resonates with us. We appreciate the value of telemedicine in cancer services and agree that tele-oncology offers excellent prospects to help patients with cancer during COVID-19 and in the future. Yet, we are confronted with the fact that there is little mentioned by the authors of the opportunities and challenges associated with integrating telemedicine education and training (ET) in tele-oncology. In response to this statement, here, we set out ways in which telemedicine ET can be integrated in tele-oncology services for medical students. In addition, we discuss challenges of telemedicine ET and propose ways to overcome these.

In this Letter article, the author's last name lacked a hyphen and therefore was incorrectly represented. The corrected author name is Andrea M. Allen-Tejerina. This has been corrected in the original online article. The authors apologize for this error.

No abstract